US Broker Ratings

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 46.99% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a formidable player in the healthcare sector, is drawing significant attention from investors due to its impressive potential upside and solid..

Halozyme Therapeutics (HALO) Investor Outlook: Unpacking the 17% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has become a compelling focal point for investors in the biotechnology sector, boasting a market capitalization of $7.04 billion. With its..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 24.62% Potential Upside Amidst Market Volatility

Avantor, Inc. (NYSE: AVTR) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating a Potential 31.88% Upside in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) has emerged as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Report: Navigating Growth Potential with a 20.10% Revenue Surge

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) presents an intriguing proposition for investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing..

STERIS plc (STE) Stock Analysis: Exploring the 15% Upside Potential

For investors eyeing the healthcare sector, STERIS plc (NYSE: STE) presents a compelling opportunity, especially with a potential upside of 15.38% based on analyst target prices...

Sarepta Therapeutics, Inc. (SRPT)

⚠️ No article content returned.

..

Novartis AG (NVS) Stock Analysis: Insights into the Healthcare Giant’s Growth and Dividend Appeal

Novartis AG (NYSE: NVS) stands as a powerhouse in the global pharmaceutical industry, commanding a substantial market presence with a market capitalization of $239.03 billion. Headquartered..

Smith & Nephew SNATS, Inc. (SNN): Investor Outlook Reveals 9.48% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, stands as a noteworthy consideration for investors focusing on the medical devices..

DexCom, Inc. (DXCM) Stock Analysis: Evaluating a 18.25% Potential Upside in the Healthcare Sector

DexCom, Inc. (DXCM), a leader in the medical devices space, commands a significant position in the healthcare sector with a market capitalization of $32.69 billion. Headquartered..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 70% Upside Potential with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a dynamic player in the biotechnology sector, presents a compelling opportunity for investors seeking substantial upside potential. With its headquarters in..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 14.62% Potential Upside with Robust Dividend Yield

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a key player in the healthcare sector’s medical devices industry, offers investors a compelling scenario characterized by a mixture of..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Dividend Yield and Potential Upside Attract Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, consistently commands attention from investors due to its robust portfolio and strategic partnerships. Operating..

Investor Outlook: Hologic, Inc. (HOLX) Shows Resilience with Strong Cash Flow and Modest Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers intriguing prospects for investors. With a..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a 28% Upside Potential Amidst Strategic Partnerships

Biogen Inc. (NASDAQ: BIIB) stands prominently within the healthcare sector, specifically among drug manufacturers. With a market capitalization of $19.67 billion, Biogen is a formidable player..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 22.71% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a noteworthy entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $7..

Guardant Health, Inc. (GH) Stock Analysis: A Diagnostic Innovator with 18.73% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology sector, stands out in the healthcare landscape with its robust portfolio of cutting-edge diagnostic solutions...

Medtronic plc (MDT) Stock Analysis: Unpacking Its 7.4% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a leading player in the medical devices industry, offers an intriguing investment opportunity with a potential upside of 7.4%, as suggested by..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on Its 62% Revenue Growth and 62% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a key player in the healthcare sector, is making significant strides in the biotechnology industry, focusing on innovative treatments for central..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 23% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable attention from investors due to its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds